Literature DB >> 20639272

Methylprednisolone infusion for life-threatening H1N1-virus infection.

Marco Confalonieri1, Rossella Cifaldi, Lorella Dreas, Marino Viviani, Marco Biolo, Marco Gabrielli.   

Abstract

BACKGROUND: During winter 2009 we treated with prolonged corticosteroid infusion eight consecutive patients affected by H1N1-virus infection and severe pneumonia. The most severe patient was a previously healthy 30-year-old man admitted to hospital because of bilateral pneumonia and severe acute respiratory failure.
METHOD: H1N1-virus infection was detected by broncho-alveolar lavage performed on day 1. After some days following admission the patient was still in a life-threatening state, not responding to oseltamivir, protective mechanical ventilation and veno-arterial extracorporeal membrane oxygenation (ECMO).
RESULTS: The addition of methylprednisolone infusion at a stress dose (1 mg/kg/24 h) as rescue therapy significantly and rapidly improved the clinical condition. Weaning from ECMO and invasive mechanical ventilation was possible within a relatively few days.
CONCLUSION: According to the literature reports more than 34% of H1N1-virus severe infections were treated with corticosteroids. This report and our experience may suggest a possible life-saving use of corticosteroids at a stress dose in severely ill patients with an H1N1-virus infection that is not responding to the most advanced treatments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20639272     DOI: 10.1177/1753465810376951

Source DB:  PubMed          Journal:  Ther Adv Respir Dis        ISSN: 1753-4658            Impact factor:   4.031


  10 in total

1.  Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.

Authors:  Masaya Fukushi; Makoto Yamashita; Tohru Miyoshi-Akiyama; Shuku Kubo; Kenji Yamamoto; Koichiro Kudo
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

2.  Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus.

Authors:  Hong-Ryang Kil; Jae-Ho Lee; Kyung-Yil Lee; Jung-Woo Rhim; You-Sook Youn; Jin-Han Kang
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

3.  Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection.

Authors:  Gernot Beutel; Olaf Wiesner; Matthias Eder; Carsten Hafer; Andrea S Schneider; Jan T Kielstein; Christian Kühn; Albert Heim; Tina Ganzenmüller; Hans-Heinrich Kreipe; Axel Haverich; Andreas Tecklenburg; Arnold Ganser; Tobias Welte; Marius M Hoeper
Journal:  Crit Care       Date:  2011-03-02       Impact factor: 9.097

Review 4.  Glucocorticosteroid in treatment of severe pneumonia.

Authors:  Felinda Ariani; Kaixiong Liu; Zhang Jing; Jieming Qu
Journal:  Mediators Inflamm       Date:  2013-12-02       Impact factor: 4.711

5.  Viruses as Sole Causative Agents of Severe Acute Respiratory Tract Infections in Children.

Authors:  Fleur M Moesker; Jeroen J A van Kampen; Annemarie M C van Rossum; Matthijs de Hoog; Marion P G Koopmans; Albert D M E Osterhaus; Pieter L A Fraaij
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

6.  Should high-dose steroid therapy and inhaled nitric oxide be considered for adult patients with H1N1 respiratory failure?

Authors:  Francesca Caliandro; Agnieszka Crerar-Gilbert; Brendan Madden
Journal:  JRSM Short Rep       Date:  2013-02-20

7.  Severe influenza treatment guideline.

Authors:  Won Suk Choi; Ji Hyeon Baek; Yu Bin Seo; Sae Yoon Kee; Hye Won Jeong; Hee Young Lee; Byung Wook Eun; Eun Ju Choo; Jacob Lee; Young Keun Kim; Joon Young Song; Seong-Heon Wie; Jin Soo Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

8.  The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010.

Authors:  Mei Zeng; Xiaoyan Zheng; Ruicheng Wei; Na Zhang; Kai Zhu; Bin Xu; Chun-Hui Yang; Chun-Fu Yang; Chaoyang Deng; Dongbo Pu; Xiaohong Wang; Ralf Altmeyer; Qibin Leng
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19

9.  Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis.

Authors:  Yi Zhang; Wenjie Sun; Erik R Svendsen; Song Tang; Raina C MacIntyre; Peng Yang; Daitao Zhang; Quanyi Wang
Journal:  Crit Care       Date:  2015-02-20       Impact factor: 19.334

10.  Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Authors:  Gerard Moreno; Alejandro Rodríguez; Luis F Reyes; Josep Gomez; Jordi Sole-Violan; Emili Díaz; María Bodí; Sandra Trefler; Juan Guardiola; Juan C Yébenes; Alex Soriano; José Garnacho-Montero; Lorenzo Socias; María Del Valle Ortíz; Eudald Correig; Judith Marín-Corral; Montserrat Vallverdú-Vidal; Marcos I Restrepo; Antoni Torres; Ignacio Martín-Loeches
Journal:  Intensive Care Med       Date:  2018-08-03       Impact factor: 17.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.